No association of HLA-DRB1*15:01 and HLA-DRB1*11 in systemic juvenile idiopathic arthritis-associated macrophage activation syndrome and other secondary hemophagocytic lymphohistiocytoses. [PDF]
Hinze CH +6 more
europepmc +1 more source
Evaluation of the real-world safety of Canakinumab in the treatment of systemic juvenile idiopathic arthritis in children aged 0-16: a comprehensive analysis based on FAERS data. [PDF]
Xiao P +8 more
europepmc +1 more source
UBE2D1 as a key biomarker in systemic juvenile idiopathic arthritis: a new perspective on diagnosis and disease activity assessment. [PDF]
Luo Q +12 more
europepmc +1 more source
Literature analysis and implication of biologic therapy for children with non-systemic juvenile idiopathic arthritis in real-world settings. [PDF]
Fung A, Yue X, Wigle PR, Guo JJ.
europepmc +1 more source
Tofacitinib treatment of systemic juvenile idiopathic arthritis: a case report and literature review. [PDF]
Zhu M +6 more
europepmc +1 more source
Utility of patient-reported outcomes for pulmonary symptoms and sleep disturbance and impairment in children with systemic juvenile idiopathic arthritis. [PDF]
Nguyen K +6 more
europepmc +1 more source
CD14<sup>+</sup>CXCL10<sup>+</sup> monocytes are associated with peripheral immune network alterations in systemic juvenile idiopathic arthritis: From multiple centers. [PDF]
Luo Q +12 more
europepmc +1 more source
Albumin and Gamma-Glutamyl Transferase as Biomarkers for Differentiating Systemic Juvenile Idiopathic Arthritis from Reactive Arthritis. [PDF]
Li F, Chen Z, Luo Q, Ma C, Tang X.
europepmc +1 more source
Blood molecular subtypes to guide precision treatment strategies in systemic juvenile idiopathic arthritis. [PDF]
Baek IW, Rhim JW, Park KS, Kim KJ.
europepmc +1 more source
Brucella bloodstream infection mimicking systemic juvenile idiopathic arthritis: a pediatric case report. [PDF]
Ling J +7 more
europepmc +1 more source

